Full Text View
Tabular View
No Study Results Posted
Related Studies
Multiple Dose Safety Study of PF-04802540 in Subjects With Schizophrenia
This study has been completed.
Study NCT00876304   Information provided by Taisho Pharmaceutical Co., Ltd.

First Received on April 3, 2009.   Last Updated on March 17, 2010   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Schizophrenia
More general conditions related to this trial
Mental Disorders
Schizophrenia and Disorders with Psychotic Features
Interventions listed in this trial
PF-04802540
Placebo
Sponsors listed in this trial
Taisho Pharmaceutical Co., Ltd.


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services